 Connection
Stephen Daniels to Hyperlipoproteinemia Type II
This is a "connection" page, showing publications Stephen Daniels has written about Hyperlipoproteinemia Type II.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
5.046 |
|
|
|
-
Santos RD, Wiegman A, Caprio S, Cariou B, Averna M, Poulouin Y, Scemama M, Manvelian G, Garon G, Daniels S. Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial. JAMA Pediatr. 2024 Mar 01; 178(3):283-293.
Score: 0.866
-
Daniels SR. What Is the Optimum Approach to Screening for Familial Hypercholesterolemia in Children? JAMA Pediatr. 2023 06 01; 177(6):565-566.
Score: 0.822
-
Daniels S, Caprio S, Chaudhari U, Manvelian G, Baccara-Dinet MT, Brunet A, Scemama M, Loizeau V, Bruckert E. PCSK9 inhibition with alirocumab in pediatric patients with heterozygous familial hypercholesterolemia: The ODYSSEY KIDS study. J Clin Lipidol. 2020 May - Jun; 14(3):322-330.e5.
Score: 0.660
-
Daniels SR. Screening for Familial Hypercholesterolemia. JAMA Cardiol. 2019 07 01; 4(7):689-690.
Score: 0.627
-
Daniels SR. How to identify children with familial hypercholesterolemia. J Pediatr. 2017 04; 183:2.
Score: 0.536
-
Daniels SR. Lipid Screening in Children. J Am Coll Cardiol. 2015 Sep 15; 66(11):1258-1260.
Score: 0.482
-
Daniels SR, Gidding SS, de Ferranti SD. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S30-7.
Score: 0.354
-
Daniels SR. Screening for familial hypercholesterolemia: what is the most effective strategy? Nat Clin Pract Cardiovasc Med. 2008 Mar; 5(3):130-1.
Score: 0.281
-
de Ferranti SD, Kazi DS, Bibbins-Domingo K, Daniels S, Howaniec B, Khera AV, Newman TB, Vernacchio L. Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood. Clin Chem. 2021 10 01; 67(10):1312-1317.
Score: 0.183
-
Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 Jun; 5(3 Suppl):S1-8.
Score: 0.089
-
Goldberg AC, Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, Robinson JG, Daniels SR, Gidding SS, de Ferranti SD, Ito MK, McGowan MP, Moriarty PM, Cromwell WC, Ross JL, Ziajka PE. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 May-Jun; 5(3):133-140.
Score: 0.088
-
de Ferranti SD, Daniels SR, Gillman M, Vernacchio L, Plutzky J, Baker AL. NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood? Clin Chem. 2012 Dec; 58(12):1626-30.
Score: 0.024
-
McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007 Apr 10; 115(14):1948-67.
Score: 0.017
-
Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006 Dec 12; 114(24):2710-38.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|